GENEVA, SWITZERLAND / ACCESSWIRE / June 2, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief"), a biopharmaceutical company with its lead compound RLF-100 (aviptadil) in advanced clinical
Findings suggest APPA has a clear anti-inflammatory effect on human articular chondrocytes involved in osteoarthritis and reduces extracellular matrix degradation of cartilage STEVENAGE
A man wanted on outstanding warrants has been charged over alleged cross-border traffic and property offences in the Murray River region. About two weeks.
EQS Group-Ad-hoc: Lonza Group AG / Key word(s): Agreement/Expansion Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands